Skip to main content
SpringerLink
Log in

Utility of laboratory tests in B-CLL patients in different clinical stages

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The study objective was to analyse the utility of laboratory tests performed in 30 patients with B-cell chronic lymphocytic leukaemia (B-CLL) at different clinical stages. Laboratory tests included automated and microscopic assessment of peripheral blood and bone marrow counts as well as evaluation of leukaemic cells. Apart from the diagnostic and prognostic value of laboratory abnormalities such as clonal lymphocytosis with CD5+CD19+CD23+ phenotype, reduced erythrocyte parameters, thrombocytopenia or bone marrow infiltration by the neoplastic clone as well as low percentage of Gumprecht’s shadows, low apoptotic activity of peripheral blood lymphocytes, and increased percentage of CD38− and ZAP-70 ± cells markedly correlate with the stage of disease progression. These results seem to confirm the diagnostic and prognostic significance of these parameters determined in routine laboratory tests in B-CLL patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Boelens J, Lust S, Vanhoecke B, Offner F. Chronic lymphocytic leukaemia. Anticancer Res. 2009;29:605–15.

    CAS  PubMed  Google Scholar 

  2. Linet MS, Schubauer-Berigan MK, Weisenburger DD, Richardson DB, Landgren O, Blair A, Silver S, Field RW, Caldwell G, Hatch M, Dores GM. Chronic lymphocytic leukaemia: an overview of etiology in light of recent developments in classification and pathogenesis. Br J Haematol. 2007;139(5):672–86.

    Article  PubMed  Google Scholar 

  3. Caligaris-Cappio F. Chronic lymphocytic leukemia: “Cinderella” is becoming a star. Mol Med. 2009;15:67–9.

    Article  CAS  PubMed  Google Scholar 

  4. Mulligan CS, Thomas ME, Mulligan SP. Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL). Blood. 2009;113:6496–7.

    Article  CAS  PubMed  Google Scholar 

  5. Giannopoulos K, Schmitt M, Kowal M, Wlasiuk P, Bojarska-Junak A, Chen J, Rolinski J, Dmoszynska A. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep. 2008;20:677–82.

    PubMed  Google Scholar 

  6. Marjanovic G, Stanojevic I, Jankovic-Velickovic Lj, Hubl W, Marjanovic V. Detection of ZAP-70 in patients with chronic lymphocytic leukemia. J BUON. 2008;13:543–6.

    CAS  PubMed  Google Scholar 

  7. Brauer M. In vivo monitoring of apoptosis. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:323–31.

    Article  CAS  PubMed  Google Scholar 

  8. Jędrzejczak W, Podolak-Dawidziak M. Standardy w hematologii. Wrocław: Volumed; 2001. wyd. 1.

  9. Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet. 2008;371:1017–29.

    Article  CAS  PubMed  Google Scholar 

  10. Hallek M. Prognostic factors in chronic lymphocytic leukemia. Ann Oncol. 2008;19:51–3.

    Article  Google Scholar 

  11. Jamroziak K, Szemraj Z, Grzybowska-Izydorczyk O, Szemraj J, Bieniasz M, Cebula B, Giannopoulos K, Balcerczak E, Jesionek-Kupnicka D, Kowal M, Kostyra A, Calbecka M, Wawrzyniak E, Mirowski M, Kordek R, Robak T. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians. Cancer Epidemiol Biomark Prev. 2009;18:945–53.

    Article  CAS  Google Scholar 

  12. Nieto WG, Almeida J, Romero A, Teodosio C, López A, Henriques AF, Sánchez ML, Jara-Acevedo M, Rasillo A, González M, Fernández-Navarro P, Vega T, Orfao A; Primary Health Care Group of Salamanca for the Study of MBL. Increased frequency (12%) of circulating CLL-like B-cell clones in healthy individuals using a high-sensitive multicolor flow cytometry approach. Blood. 2009;114:33–37

    Article  CAS  PubMed  Google Scholar 

  13. Sieklucka M, Pozarowski P, Bojarska-Junak A, Hus I, Dmoszynska A, Rolinski J. Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III–IV Rai stage patients and poor outcome. Oncol Rep. 2008;19(6):1611–20.

    CAS  PubMed  Google Scholar 

  14. Nowakowski GS, Hoyer JD, Shanafelt TD, Zent CS, Call TG, Bone ND, Laplant B, Dewald GW, Tschumper RC, Jelinek DF, Witzig TE, Kay NE. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia. J Clin Oncol. 2009;27:1844–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360:659–67.

    Article  CAS  PubMed  Google Scholar 

  16. Kaufman M, Rubin J, Rai K. Diagnosing and treating chronic lymphocytic leukemia in 2009. Oncology. 2009;23:1030–7.

    PubMed  Google Scholar 

  17. Ertault-Daneshpouy M, Noguera ME, Gisselbrecht C, Haddad A, Brice P, Marolleau JP, Soulier J, Mounier N. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2008;6:55–63.

    PubMed  Google Scholar 

  18. Ibrahim S, Keating M, Do KA, O’Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001;98:181–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematological Diagnostics, Medical University of Bialystok, Waszyngtona 15a, 15-276, Białystok, Poland

    Małgorzata Rusak, Joanna Osada, Joanna Pawlus, Joanna Chociej-Stypułkowska & Milena Dąbrowska

  2. Department of Haematology, University Hospital in Bialystok, Białystok, Poland

    Janusz Kłoczko

Authors
  1. Małgorzata Rusak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna Osada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanna Pawlus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joanna Chociej-Stypułkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Milena Dąbrowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Janusz Kłoczko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Pawlus.

About this article

Cite this article

Rusak, M., Osada, J., Pawlus, J. et al. Utility of laboratory tests in B-CLL patients in different clinical stages. Int J Hematol 93, 736–744 (2011). https://doi.org/10.1007/s12185-011-0862-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0862-3

Keywords

Search

Navigation